Blade Air Mobility, INC Form 4 insider transactions
Strata Critical Medical's Chief Accounting Officer, Amir Cohen, reported a disposition of 3,716 shares of Class A common stock to cover tax obligations related to restricted stock unit vesting.
William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., purchased 17,000 shares of Class A common stock but subsequently disgorged short-swing profits to the Issuer.
Strata Critical Medical Director Andrew Lauck purchased 5,000 shares of Class A common stock, signaling insider confidence.
Scott M. Wunsch, CEO of Trinity Air Medical and Director at Strata Critical Medical, Inc., was granted 13,395 Restricted Stock Units.
Strata Critical Medical, Inc. CEO Louis R. Verdetto received a grant of 63,918 Restricted Stock Units, aligning executive incentives with future company performance.
William L. Cook III, a Director at Strata Critical Medical, Inc. (SRTA), was granted 53,233 Restricted Stock Units (RSUs) as part of his compensation.
Reginald Love, a Director at Strata Critical Medical, Inc., reported the sale of 11,000 shares of Class A common stock at $4.37 per share.
Reginald Love, a Director at Strata Critical Medical, Inc., reported the sale of 11,000 shares of Class A common stock on November 19, 2025, at a weighted average price of $4.3122 per share.
Strata Critical Medical Co-CEO and General Counsel Melissa M. Tomkiel acquired 27,778 shares of Class A common stock through option exercise.
Strata Critical Medical's Chief Accounting Officer, Amir Cohen, reported the acquisition and subsequent tax-related disposition of company stock.
Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, reported the acquisition of 208,929 shares from PSU vesting and the disposition of 106,659 shares for tax obligations.
Strata Critical Medical's Co-CEO and CFO, William A. Heyburn, acquired 181,072 shares through PSU vesting and subsequently disposed of 100,133 shares for tax obligations.
Melissa M. Tomkiel, Co-CEO of Strata Critical Medical, Inc., exercised options to acquire 55,556 shares of Class A common stock at $0.18 per share.
Melissa M. Tomkiel, Co-CEO of Strata Critical Medical, Inc., exercised 55,555 stock options at $0.18 per share, increasing her direct ownership of Class A common stock.
Scott M. Wunsch, CEO of Trinity Air Medical and an officer of Strata Critical Medical, Inc., reported a disposition of 2,378 shares of Class A common stock to cover tax obligations.
Strata Critical Medical's Co-CEO and CFO, William A. Heyburn, reported a disposition of 35,348 shares of Class A common stock for tax withholding purposes.
Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, had 34,018 shares withheld for tax obligations related to restricted stock unit vesting.
Strata Critical Medical's Chief Accounting Officer, Amir Cohen, disposed of 3,707 shares of Class A common stock to cover tax obligations related to restricted stock unit vesting.
Strata Critical Medical, Inc. Director Robert S. Wiesenthal reported the acquisition of 40,607 Restricted Stock Units and an amendment to the vesting conditions of 920,477 previously granted RSUs.
Strata Critical Medical, Inc. granted its Chief Accounting Officer, Amir Cohen, 11,844 fully vested Restricted Stock Units.
Strata Critical Medical, Inc. director Andrew Lauck received a grant of 11,844 fully vested Restricted Stock Units, effective upon the completion of the company's Passenger business sale.
Form 4: BLDE CEO Granted 22,365 RSUs
Scott M. Wunsch, CEO of Trinity Air Medical, a subsidiary of Blade Air Mobility, Inc., was granted 22,365 Restricted Stock Units (RSUs) vesting December 8, 2025.
Blade Air Mobility's President and General Counsel, Melissa M. Tomkiel, increased her direct ownership by exercising stock options.
Blade Air Mobility CEO Robert S. Wiesenthal exercised stock options to acquire 282,470 shares of Class A common stock.
Blade Air Mobility, Inc. Director Andrew Lauck was granted 35,534 Restricted Stock Units, vesting at the 2026 Annual Meeting of Stockholders.
Blade Air Mobility, Inc. Director Edward M. Philip received a grant of 35,534 Restricted Stock Units, vesting in 2026.
Blade Air Mobility's Chief Accounting Officer, Amir Cohen, acquired shares from PSU vesting and disposed of shares for tax obligations.
Blade Air Mobility, Inc. Director Eric Affeldt was granted 35,534 Restricted Stock Units, vesting fully at the 2026 Annual Meeting.
Blade Air Mobility CEO Robert Wiesenthal increased his direct beneficial ownership by 110,166 shares following the vesting of performance-based restricted stock units.
Blade Air Mobility's President and General Counsel, Melissa M. Tomkiel, reported the sale of company stock following the vesting of performance-based restricted stock units.